PURPOSE OF REVIEW: To summarize recent findings and developments in the field of the relation between white-matter lesions and cognition. RECENT FINDINGS: Recent studies have provided further evidence that white-matter lesions exert a detrimental effect on cognitive profile. New magnetic-resonance techniques may help in clarifying the meaning and extent of this effect. Evidence is also increasing about lesion progression occurring over time, at least in patients with severe white-matter lesions, and this progression is one of the factors related to cognitive decline in the elderly. The need to delay or halt the progression of white-matter lesions has led to clarification of the role of some risk factors and to performance of therapeutic trials where white-matter lesions are used as a surrogate marker for the end point of small-vessel disease. In addition to cognitive effects, white-matter lesions have a role in the decline of other functional performances, and this places individuals with higher-grade lesions at increased risk of developing disability. SUMMARY: White-matter lesions cannot be considered as mere incidental findings, at least in patients who show severe lesions. The pathogenesis of white-matter lesions must be clarified further and strategies found to delay their progression.
PURPOSE OF REVIEW: To summarize recent findings and developments in the field of the relation between white-matter lesions and cognition. RECENT FINDINGS: Recent studies have provided further evidence that white-matter lesions exert a detrimental effect on cognitive profile. New magnetic-resonance techniques may help in clarifying the meaning and extent of this effect. Evidence is also increasing about lesion progression occurring over time, at least in patients with severe white-matter lesions, and this progression is one of the factors related to cognitive decline in the elderly. The need to delay or halt the progression of white-matter lesions has led to clarification of the role of some risk factors and to performance of therapeutic trials where white-matter lesions are used as a surrogate marker for the end point of small-vessel disease. In addition to cognitive effects, white-matter lesions have a role in the decline of other functional performances, and this places individuals with higher-grade lesions at increased risk of developing disability. SUMMARY:White-matter lesions cannot be considered as mere incidental findings, at least in patients who show severe lesions. The pathogenesis of white-matter lesions must be clarified further and strategies found to delay their progression.
Authors: Rosalind Brown; Helene Benveniste; Sandra E Black; Serge Charpak; Martin Dichgans; Anne Joutel; Maiken Nedergaard; Kenneth J Smith; Berislav V Zlokovic; Joanna M Wardlaw Journal: Cardiovasc Res Date: 2018-09-01 Impact factor: 10.787
Authors: M Edip Gurol; Anand Viswanathan; Christopher Gidicsin; Trey Hedden; Sergi Martinez-Ramirez; Andrew Dumas; Anastasia Vashkevich; Alison M Ayres; Eitan Auriel; Ellis van Etten; Alex Becker; Jeremy Carmasin; Kristin Schwab; Jonathan Rosand; Keith A Johnson; Steven M Greenberg Journal: Ann Neurol Date: 2013-02-19 Impact factor: 10.422
Authors: Juan José Soriano-Raya; Júlia Miralbell; Elena López-Cancio; Núria Bargalló; Juan Francisco Arenillas; Maite Barrios; Cynthia Cáceres; Pere Toran; Maite Alzamora; Antoni Dávalos; Maria Mataró Journal: J Cereb Blood Flow Metab Date: 2014-02-19 Impact factor: 6.200